Program
ATA Annual Meeting Program/Schedule at a Glance
Basic Science Track
This year’s program has a dedicated programming track for basic scientists. Click here to learn more.
Wednesday, October 30, 2024
7:00 AM – 6:00 PM
Registration Open
7:30 AM – 5:00 PM
Endocrine Neck Advanced Utrasound Course (Additional Registration Required)
8:00 AM – 2:00 PM
ATA Board of Directors Meeting (Invite Only)
8:00 AM – 5:00 PM
E. Chester Ridgway Trainee Conference (Additional Registration Required)
7:45 AM – 4:30 PM
Leadership Development Workshop (Additional Registration Required)
8:00 AM – 5:00 PM
Introduction to Interventional Endocrinology Course (Additional Registration Required)
2:00 PM – 6:00 PM
ATA Committee/Guidelines/Task Force Meetings
Dinner & Networking on Your Own
Thursday, October 31, 2024
7:15 AM – 6:30 PM
Registration Open
7:30 AM – 8:00 AM
Opening Remarks & Year in Thyroidology Speaker Introductions
- Michael McDermott, MD, President
- Whitney Goldner, MD, Program Committee Co-Chair
- Meredith Hartley, PhD, Program Committee Co-Chair
8:00 AM – 9:00 AM
Year in Thyroidology
- Whitney Goldner, MD – Co-Chair
- Meredith Hartley, PhD – Co-Chair
- Douglas Forrest, PhD – Basic Science Year in Review
- Jennifer Sipos, MD – Clinical Science Year in Review
- Elizabeth Gardner Grubbs, MD – Surgical Year in Review
9:10 AM – 10:10 AM
Oral Abstracts (3 concurrent)
10:15 AM – 11:15 AM
Poster Session 1 & Coffee Break
Expo Theater
10:15 AM – 6:30 PM
Exhibit Hall Open
11:30 AM – 12:30 PM
Parallel Sessions (4 concurrent)
-
Non Surgical Interventions
- Jennifer Hong Kuo, MD -Chair
- Victoria E. Banuchi, MD
- Claire Elizabeth Graves, MD
- Debra J. Margulies, MD
-
Decoding Thyroid Cancer: Unraveling the Impact of Epigenetics on Development, Tumor Microenvironment, and Immune Response
- Salma Khan, MBBS, PhD – Co-Chair
- Mabel Ryder, MD – Co-Chair
- Aime T. Franco, PhD
- Joanna Klubo-Gwiezdzinska, MD, PhD
- Carmelo Nucera, MD, PhD
-
Navigating Thyroid Eye Disease: Diagnosis, Management and Multidisciplinary Collaborations
- David S. Cooper, MD – Co-Chair
- Tracy Susan Tylee, MD – Co-Chair
- Chrysoula Dosiou, MD
- Suzanne K. Freitag, MD
-
Debate: What are the best thyroid function tests to monitor hypothyroidism?
- Whitney S. Goldner, MD – Chair
- Donald S. A McLeod, MD – TSH Only Position
- Elizabeth A. McAninch, MD – TSH, T4,T3 Position
12:30 PM – 1:45 PM
Networking and Lunch on Your Own
12:40 PM – 1:40 PM
Expo Theater
1:50 PM – 2:50 PM
Van Meter & Braverman Award Lectures
- Erik K. Alexander, MD – Braverman Award Lecture
3:00 PM – 4:00 PM
Poster Session 2 & Coffee Break
Diversity, Equity and Inclusion Networking Session
Expo Theater
4:10 PM – 5:10 PM
Parallel Sessions (4 concurrent)
-
Controversies in Treatment of Intermediate Risk Thyroid Cancer with RAI?
- Laura Boucai, MD – Chair
- Bryan R. Haugen, MD
- Steven I. Sherman, MD
- Jolanta M. Durski, MD
-
Managing Hypoparathyroidism
- Raquel A. Cano, MD, PhD – Co-Chair
- Jessica Barbara Shank, MD – Co-Chair
- Laura Ryan, MD – Long term management of chronic hypoparathyroidism: what is new?
- David Steward, MD – Special Surgical Considerations for Hyperparathyroidism
- Tamara Vokes, MD – Quality of life and long term consequences of hypoparathyroidism
-
Chromatin Remodeling and Epigenetics in TR Action
- Anthony N. Hollenberg, MD – Co-Chair
- Liezhen Fu, PhD – Co-Chair
- Laurent Sachs, PhD – Thyroid hormone on Transcriptome and Methylome in Xenopus tropicalis tadpoles
- Frances E. Carr, PhD – TR and chromatin remodeling
- Young Wook Cho, PhD – Thyroid hormone-regulated chromatin landscape and transcriptional sensitivity of the pituitary gland
-
Meet the Professor: Designing a Clinical Trial
- Marcia Brose, MD – Chair
- Susan C. Pitt, MD
5:15 PM
All Attendee Photo
5:30 PM – 6:30 PM
Bobbi Smith Networking Social: Halloween Happy Hour
Dinner & Networking on your own
Friday, November 1, 2024
Expo Theater
7:15 AM – 5:00 PM
Registration Open
7:45 AM – 8:00 AM
Recognition of Stanbury Medal & Distinguished Service Award and Morning Announcements from Co-Chairs
- Stephen LaFranchi, MD – John B. Stanbury Thyroid Pathophysiology Medal
- Elizabeth N. Pearce, MD – Distinguished Service Award
8:00 AM – 9:00 AM
Galton & Ingbar Lectures
- Anna M. Sawka, MD, PhD – Galton Lecture
- Mingzhao Xing, MD, PhD – Ingbar Lecture
9:10 AM – 10:10 AM
Parallel Sessions (4 concurrent)
-
MTC Guidelines Update: Systemic Therapies
- Ellen Marqusee, MD – Chair
- Mimi Hu, MD
- Tania Jaber, MD
-
Meet the Professor: Insights into Thyroid Disease: Tapping into Single-Cell & Spatial ‘Omics
- Meredith D. Hartley, PhD – Chair
- Melissa Genevieve Lechner, MD, PhD
-
Late Breaking: Emerging Clinical Applications of Thyroid Hormone Analogs
- Gregory A. Brent, MD – Chair
- TBD – Thyroid Hormone Analogs in Liver Disease
- Thomas S. Scanlan, PhD – Brain Penetrating Thyromimetics for Neurodegeneration and Affective Disorders
- Ferdy van Geest, MD – Thyroid Hormone Analogs & MCT8 Deficiency
-
Meet the Professor: Limitations of current thyroid hormone assays
- Ivana Petrovic CLS, MSc – Chair
- Josef Köhrle, PhD
10:15 AM – 11:15 AM
Poster Session 3 & Coffee Break
Expo Theater
Basic Science Networking Session
- Co-Chairs: Anthony N. Hollenberg, MD, Meredith Hartley, PhD & Edward Visser, MD
10:15 AM – 4:00 PM
Exhibit Hall Open
11:30 AM – 12:45 PM
Parallel Sessions
-
Thyroid Nodules Guidelines
- Allen S. Ho, MD – Chair
- Susan J. Mandel, MD
- Lisa A. Orloff, MD
-
Mechanisms of Thyroid Hormone Action in the Brain
- Federico Salas-Lucia, PhD- Co-Chair
- Robert Opitz, MD – Co-Chair
- Nilhan Gunhanlar, PhD – Stem-cell based models for human fetal brain development
- Thomas W. Bastian, PhD – Cell-intrinsic Effects of Iron Deficiency on Thyroid Hormone Action During Neuronal Development
- Steffen Mayerl, PhD – Cell-autonomous regulation by thyroid hormone transporters
12:45 PM – 2:00 PM
Networking and Lunch on Your Own
12:45 PM – 1:45 PM
Expo Theater
2:00 PM – 3:00 PM
Parallel Sessions (3 concurrent)
-
Endocrine Disrupting Chemicals, Disparities, and Thyroid Disease
- Leonidas Duntas, MD – Co-Chair
- Aarti Mathur – Co-Chair
- Elizabeth N. Pearce, MD – Multifaceted effects of EDCs on thyroid function over the lifespan
- Maaike Van Gerwen, MD, PhD – PFAS and Thyroid Cancer
- Robert Sargis, MD – Environmental injustices: New insights into thyroid health disparities
-
Meet the Professor: Advances in cell lines and organoids for thyroid biology and cancer
- Rebecca E. Schweppe, PhD – Chair
- Iñigo Landa, PhD – Thyroid cancer cell lines: which one to choose?
- Hendrik Julian Undeutsch, PhD – Thyroid Gland Organoids: application for physiology and cancer biology
-
Evolving concepts in the management of hyperthyroidism
- Sun Y. Lee, MD – Co-Chair
- Rokshana Raschid Thandar, MD – Co-Chair
- Brian W. Kim, MD – Changing attitudes towards traditional therapies for hyperthyroidism
- Carla Moran, MB, ChB – Severe thyrotoxicosis: What do you do when conventional treatment is not enough?
- Marius Stan, MD – Hyperthyroidism management at an inflexion point- what the future holds
2:00 PM – 4:15 PM
ATA Surgical Symposium
3:00 PM – 4:00 PM
Poster Session 4 & Coffee Break
Expo Theater
Training Program Director Networking Session
4:05 PM – 5:05 PM
Oral Abstracts (2 concurrent)
Highlights of ATA Research Grants
- Jesse David Pasternak, MD – Chair
- Theodora Pappa, MD, PhD
- Iñigo Landa, PhD
- Martyn Bullock, PhD
- Thomas W. Bastian, PhD
- Julio Cezar M. Ricarte-Filho, PhD
5:15 PM – 6:15 PM
Sawin Lecture
- Kenneth Burman, MD – Chair
- Angela M. Leung, MD, MSc – “Landmark Discoveries in Maternal-Fetal Thyroid Disease Over the Past Century”
6:20 PM – 7:00 PM
Membership Meeting
Dinner & Networking on your own
Saturday, November 2, 2024
7:45 AM – 5:00 PM
Registration Open
8:00 AM – 8:05 AM
Morning Announcements from Co-Chairs
- Whitney Goldner, MD
- Meredith Hartley, PhD
8:05 AM – 9:05 AM
Plenary: Retiring the Words Burnout and Resiliency (Planned by Women in Thyroidology)
- Naifa Lamki Busaidy, MD – Chair
- Hala Sabry DO, MBA
9:15 AM – 10:15AM
Parallel Sessions (4 concurrent)
-
Molecular Testing and its Role in Personalized Management of Thyroid Cancer
- Mayumi Endo, MD – Chair
- Rossella Elisei, MD – Dissecting the role of fusions in thyroid cancer (DTC and MTC)
- Matti Lauren Gild, MBBS – Prognostic implications of other mutations besides fusions in patients with thyroid cancer
- Ali Alzahrani, MD – Molecular testing at different stages of thyroid cancer management
-
Thyroid Hormone and Metabolism
- Sheue-yann Cheng, PhD – Co-Chair
- Tatiana L. Fonseca, PhD – Co-Chair
- Megan Jean Ritter, MD – Thyroid hormone coregulator and liver metabolism
- Hao Ying, PhD – Thyroid hormone regulation of adipocyte development
- Madhulika Tripathi, PhD – Talk Title TBD
-
Beyond the Scar: Navigating Fertility, Bone and Cardiac Health in Thyroid Cancer Survivors
- Kristien Boelaert, MD, PhD – Co-Chair
- Kaniksha Shekhar Desai, MD – Co-Chair
- Rima Dhillon-Smith, MB ChB, PhD – Fertility
- Megan R. Haymart, MD – Bone health
- Anna M. Sawka, MD, PhD – Cardiovascular health
-
Concerns and Obstacles to AI Adoption in Thyroidology
- Franklin Neil Tessler, MD – Co-Chair
- David Toro-Tobon, MD – Co-Chair
- Nikita Pozdeyev, MD, PhD – Data quality, performance, trust and reliability
- Naykky Maruquel Singh Ospina, MD – Regulatory, safety and privacy concerns
- Juan P. Brito Campana, MD – Access, knowledge and training/Workforce and Job Security
10:25 AM – 11:25 AM
Poster Session 5 & Coffee Break
Expo Theater
10:15 AM – 2:30 PM
Exhibit Hall Open
11:30 AM – 12:45 PM
Networking and Lunch on Your Own
Making definitive decisions in your life and career without hesitancy or regret: Networking Session Planned by Women in Thyroidology
11:45 PM – 12:45 PM
Expo Theater
1:00 PM – 2:00 PM
Parallel Sessions
-
T4/T3 combination therapy for hypothyroidism – where are we now?
- Marco Medici, MD, PhD – Co-Chair
- Mary H. Samuels, MD – Co-Chair
- Antonio C. Bianco, MD, PhD – What is the physiological basis for using T3 in patients with hypothyroidism?
- Jacqueline Jonklaass, MD, PhD – Effects of levothyroxine monotherapy and T4/T3 combination therapy of patients’ quality of life
- Peter N. Taylor, MB, ChB – Joint British Thyroid Association Guidelines on the use of liothyronine in hypothyroidism.
-
Thyroid Hormone Actions in Morphogenesis and Regeneration
- Yun-Bo Shi, PhD – Co-Chair
- Alex M. Schreiber, PhD – Co-Chair
- J. David Furlow, PhD – A tale of two receptors: TR and RXR interactions in Xenopus development
- Erica Crespi, PhD – Investigating the role of thyroid hormone in the regulation of regeneration: Is timing everything?
- Guo Huang, MD – Thyroid hormone and regeneration capacity of the heart
-
Thyroid Dialogues: Practical Aspects of a Thyroid Cancer Survivorship Clinic
- Maria Papaleontiou – Chair
- Anne M. Knape, NP
- Michele Merten, NP
1:00 PM – 4:00 PM
ATA Pediatric Thyroid Symposium
2:10 PM – 3:10 PM
Parallel Sessions
-
Thyroid Dialogues: Artificial Intelligence in Scientific Publishing
- Anna M. Sawka, MD, PhD – Co-Chair
- Julie Ann Sosa, MD – Co-Chair
- Sonja Krane, PhD – Publishing Perspective on Manuscript Submissions & Review
- Melissa Kacena, PhD – AI & Manuscript Development
- TBD – Ethical Considerations
- Putting into Practice New Pathologic Entities 2023 Bethesda and 2022 WHO: Insightful Case Presentations
- Sarah L. Rhode, MD – Chair
- Zubair W. Baloch, MD, PhD
- Justine Barletta, MD
- Fernanda Vaisman, MD, PhD
-
Neoadjuvant Therapy for Thyroid Cancer
- Sarimar N. Agosto Salgado, MD – Co-Chair
- Ramona Dadu, MD – Co-Chair
- Richard J. Wong, MD, FACS – Anaplastic Thyroid Cancer
- Bhavana Konda, MD – Differentiated Thyroid Cancer
- Mark Zafereo, MD – Medullary Thyroid Cancer
2:10 PM – 3:10 PM
Trainee Only: Fundamentals of Thyroid Ultrasound
- F. Thurston Drake, MD – Chair
- Susan J. Mandel, MD
3:15 PM – 4:15PM
Oral Abstracts (3 concurrent)
4:30 PM – 5:45 PM
Parallel Sessions
-
Differentiated Thyroid Cancer Guidelines Update
- R. Michael Tuttle, MD – Chair
- Julie Ann Sosa, MD
- Matthew D. Ringel, MD
-
Translational Insights in Thyroid Hormone Resistance due to Mutations in TRalpha
- W. Edward Visser, MD – Co-Chair
- Karn Wejaphikul, MD, PhD – Co-Chair
- Vengalil Krishna Chatterjee, MD – Clinical management in patients with RTHa
- Marcel Meima, PhD – Molecular mechanisms underlying neurocognitive variability in RTHa
- Luca Persani, MD, PhD – Expression of mutant TRalpha in zebrafish embryos
6:00 PM – 8:00 PM
Dinner on your own
8:00 PM – 10:00 PM
Annual Meeting Closing Party (Additional Registration Required)
Networking and Lunch on Your Own
Sunday, November 3, 2024
8:00 AM – 11:00 AM
Registration Open
8:15 AM – 9:30 AM
Parallel Sessions
-
Thyroid & Pregnancy Guidelines Update
- Spyridoula Maraka, MD – Chair
- Angela M. Leung, MD, MSc
- Tim Korevaar, MD, PhD
-
Thyroid Hormone Regulation of Stem Cells in Diverse Organ Systems
- Soledad Barez Lopez, PhD – Co-Chair
- Thomas S. Scanlan, PhD – Co-Chair
- Michelina Plateroti, PhD – Impact of the Thyroid hormone nuclear Receptor TRa1 in intestinal stem cells physiopathology
- Sylvie Remaud, PhD – Long-term functional consequences on neurogliogenesis of perinatal modulation of thyroid hormone action
- Jeff Huang, PhD – How does thyroid hormone influence the cell fate of adrenocortical cells?
9:45 AM – 11:00 AM
Parallel Sessions
-
Tumor Board
- David C. Shonka, MD – Co-Chair
- Sarah Emily Mayson, MD – Co-Chair
- Sara Ahmadi, MD
- Nicole Massoll, MD
- Francis Worden, MD
- Michael W. Yeh, MD
-
Basic Models and Translational Studies: Pathogenesis of Autoimmune Thyroid Disease
- Gregory A. Brent, MD – Co-Chair
- Vivian Lee Weiss, MD, PhD – Co-Chair
- Michelle Rengarajan, MD, PhD
- Daham Kim, MD, PhD – Mouse Models for Investigating Graves’ Disease and Associated Orbitopathy
- Fabiana Pani, MD – Thyroid autoimmunity and thyroid cancer: biological and translational insights from a new mouse model
11:00 AM